Sign in

CIK 0001439222 · Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-22 Washburn Theodore James Jr. Principal Accounting Officer Option exercise +167 2,716
2022-02-22 Washburn Theodore James Jr. Principal Accounting Officer Shares withheld for taxes −59 $29.08 $2K 2,657
2022-02-22 Washburn Theodore James Jr. Principal Accounting Officer Option exercise · Restricted stock units −167 0
2022-02-18 Gheuens Sarah Chief Medical Officer Option exercise +3,271 8,723
2022-02-18 Gheuens Sarah Chief Medical Officer Option exercise · Performance share units −3,271 3,272
2022-02-18 Poddar Richa Chief Commercial Officer Option exercise +1,884 4,525
2022-02-18 Poddar Richa Chief Commercial Officer Option exercise · Performance share units −1,884 1,883
2022-02-18 Car Bruce Chief Scientific Officer Option exercise +6,874 18,793
2022-02-18 Car Bruce Chief Scientific Officer Option exercise · Performance share units −6,874 6,874
2022-02-18 Biller Jonathan Chief Financial Officer Option exercise +8,523 25,641
2022-02-18 Biller Jonathan Chief Financial Officer Option exercise · Performance share units −8,523 8,522
2022-02-18 FOUSE JACQUALYN A Chief Executive Officer Option exercise +12,379 78,571
2022-02-18 FOUSE JACQUALYN A Chief Executive Officer Option exercise · Performance share units −12,379 12,380
2022-02-16 Washburn Theodore James Jr. Principal Accounting Officer Sale −233 $30.81 $7K 2,549
2022-02-14 FOUSE JACQUALYN A Chief Executive Officer Option exercise +11,334 69,697
2022-02-14 FOUSE JACQUALYN A Chief Executive Officer Shares withheld for taxes −3,505 $30.50 $107K 66,192
2022-02-14 FOUSE JACQUALYN A Chief Executive Officer Option exercise · Restricted stock units −11,334 11,333
2022-02-14 Burns James William Chief Legal Officer Option exercise +1,738 11,189
2022-02-14 Burns James William Chief Legal Officer Option exercise +5,250 16,439
2022-02-14 Burns James William Chief Legal Officer Shares withheld for taxes −2,155 $30.50 $66K 14,284

Page 37 of 48 · 941 trades